about
Imposed Work of Breathing for Flow Meters with In-Line versus Flow-Through Technique during Simulated Neonatal Breathing.Nasal CPAP and surfactant for treatment of respiratory distress syndrome and prevention of bronchopulmonary dysplasia.Neonatal care of very-low-birthweight infants in special-care units and neonatal intensive-care units in Stockholm. Early nasal continuous positive airway pressure versus mechanical ventilation: gains and losses.Initial stabilisation of preterm infants: a new resuscitation system with low imposed work of breathing for use with face mask or nasal prongs.Seven Ventilators Challenged With Leaks During Neonatal Nasal CPAP: An Experimental Pilot Study.Extremely preterm infants who are small for gestational age have a high risk of early hypophosphatemia and hypokalemia.Bronchopulmonary dysplasia: clinical grading in relation to ventilation/perfusion mismatch measured by single photon emission computed tomography.Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trial.Two-year outcomes of a randomized controlled trial of inhaled nitric oxide in premature infants.Survey shows large differences between the Nordic countries in the use of less invasive surfactant administration.A pilot study of inhaled nitric oxide in preterm infants treated with nasal continuous positive airway pressure for respiratory distress syndrome.Return of neonatal CPAP resistance - the Medijet device family examined using in vitro flow simulations.Cerebral MRI findings in a cohort of ex-preterm and control adolescents.Neonatal intestinal colonization with Extended-Spectrum β-Lactamase-producing Enterobacteriaceae - a five-year follow-up study.Endogenous nitric oxide in the upper airways of premature and term infants.A technique for lung ventilation-perfusion SPECT in neonates and infants.Low Diversity of Human Milk Oligosaccharides is Associated with Necrotising Enterocolitis in Extremely Low Birth Weight InfantsResuscitation and ventilation strategies for extremely preterm infants: a comparison study between two neonatal centers in Boston and StockholmBlunted peripheral chemoreceptor response to hyperoxia in a group of infants with bronchopulmonary dysplasiaDownregulatory cytokines in tracheobronchial aspirate fluid from infants with chronic lung disease of prematuritySingle breath analysis of endogenous nitric oxide in the newbornBudesonide delivered by dosimetric jet nebulization to preterm very low birthweight infants at high risk for development of chronic lung disease[Comment to a Cochrane review. HFOV or conventional ventilation for newborn infants with severe respiratory failure]Ureaplasma urealyticum, erythromycin and respiratory morbidity in high-risk preterm neonatesGenetic susceptibility to retinopathy of prematurityImplementation of surfactant treatment during continuous positive airway pressure[Premature infants benefit from inhaled nitric oxide, too. Not only full-term infants with severe hypoxic respiratory failure]Comparison of seven infant continuous positive airway pressure systems using simulated neonatal breathingComparison of nasal continuous positive airway pressure delivered by seven ventilators using simulated neonatal breathing
P50
Q35698403-8EA647E6-878B-4DBB-BF9D-3BB282181C8DQ37538867-EB965404-5C68-41B6-BF52-09732F0D01BFQ39447159-501B1E93-98A9-415B-908C-318C3BA330B5Q39461566-DA3B31BF-6E9B-4A3E-B8E0-E0EA649B6141Q41349646-C261A60F-EBF9-4987-AD4C-654FA8F78E63Q41650154-8A952A5F-9AD0-4BFE-BCCA-74013D2950E5Q44989246-28B65F26-3ECF-4625-8EE1-AB2AF416B9B5Q45025783-AEFFC797-76A0-4C2C-B1E9-9CBEB5DED74DQ46104969-0B53E48B-3E22-4CF6-A6C1-E70BA7D83C5CQ47604126-289F4FFD-9EAD-40DC-8B8D-71AE8FCDEA67Q47828498-A8293185-FDF5-4600-A96B-0D13A0A57D7CQ47831179-48C132F4-063B-445D-A33F-F899F8B3D78CQ48599852-C0773906-C229-4717-9A2C-53EAF12256C6Q50079043-097AE29A-A6C6-4A28-B1F1-1D696B426AB9Q51533229-9DA5995A-133F-4D6C-808B-97C95B6CC3F9Q53445825-A208153A-43D1-4701-AF4D-5F2D362A1E96Q57808811-5C8908BD-6A5B-4337-AE5B-506C10AAA76CQ62983553-0525667D-285A-4777-BF4F-14FE5ADD911FQ70921798-0BD23A07-1515-4C8C-8B89-AE81F57D2708Q73268909-5559CB5F-33F2-48C0-A092-515BD83FBF9AQ73379516-CBB5D356-CA51-49A7-A5EE-A87ACEA822B5Q73480608-0C7BCF44-90C5-431A-B69B-D68D8C378EA5Q77466729-120AE836-4F8C-4886-9B54-681754330CCEQ77591326-A8542345-8784-4FDD-A37B-71BEB1156C6FQ79322970-30CB2C84-EA61-4281-9535-34265F039767Q80258186-5BDCBA78-DF4E-4824-959F-6347F3EE3969Q82319994-F1E5756D-BEC9-46EB-A075-847290552FE5Q84984864-21683F5B-FE10-4B51-AE14-CA4C42FCC348Q86202052-2AA60083-C852-4B4F-9B9B-5B1F5FE13A06
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0002-9812-732X
@en
name
Baldvin Jonsson
@ast
Baldvin Jonsson
@en
Baldvin Jonsson
@es
Baldvin Jonsson
@nl
type
label
Baldvin Jonsson
@ast
Baldvin Jonsson
@en
Baldvin Jonsson
@es
Baldvin Jonsson
@nl
prefLabel
Baldvin Jonsson
@ast
Baldvin Jonsson
@en
Baldvin Jonsson
@es
Baldvin Jonsson
@nl
P106
P31
P496
0000-0002-9812-732X